KiSS-1, a novel human malignant melanoma metastasis-suppressor gene

Journal of the National Cancer Institute

Volumn 88, Issue 23, 1996, Pages 1731-1737

  Lee, Jeong Hyung ^b   Miele, Mary E ^b   Hicks, Deana J ^b   Phillips, Karen K ^b   Trent, Jeffery M ^b   Weissman, Bernard E ^b   Welch, Danny R ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER RISK; CHROMOSOME 6; GENE MUTATION; HUMAN; HUMAN CELL; MELANOMA; METASTASIS; TUMOR SUPPRESSOR GENE;

EID: 0029808561     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/88.23.1731     Document Type: Article

References (46)

1. Liotta LA, Stetler-Stevenson WG. Tumor invasion and metastasis: an imbalance of positive and negative regulation. Cancer Res 1991:51(18 Suppl):5054s-9s.
2. Liotta LA, Steeg PS, Stetler-Stevenson WG. Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell 1991; 64:327-36.
3. Fidler U, Ellis LM. The implications of angiogenesis for the biology and therapy of cancer metastasis [see comment citation in Medline]. Cell 1994; 79:185-8.
4. Nicolson GL. Cancer progression and growth: relationship of paracrine and autocrine growth mechanisms to organ preference of metastasis. Exp Cell Res 1993;204:171-80.
5. Dear TN, Kefford RF. Molecular oncogenetics of metastasis. Mol Aspects Med 1990;11:243-324.
6. Wright JA, Egan SE, Greenberg AH. Genetic regulation of metastatic progression. Anticancer Res 1990;10:1247-55.
7. MacDougall JR, Matrisian LM. Contributions of tumor and stromal matrix metalloproteinases to tumor progression, invasion and metastasis. Cancer Metastasis Rev 1995;14:351-62.
8. Fodstad O, Kjonniksen I. Microenvironment revisited: time for reappraisal of some prevailing concepts of cancer metastasis. J Cell Biochem 1994; 56:23-8.
9. Ponta H, Hofmann M, Herrlich P. Recent advances in the genetics of metastasis. Eur J Cancer 1994;30A:1995-2001.
10. Degen WG, Weterman MA, van Groningen JJ, Cornelissen IM, Lemmers JP, Agterbos MA, et al. Expression of nma, a novel gene, inversely correlates with the metastatic potential of human melanoma cell lines and xenografts. Int J Cancer 1996;65:460-5.
11. Safarians S, Sternlicht MD, Freiman CJ, Huaman JA, Barsky SH. The primary tumor is the primary source of metastasis in a human melanoma/scid model. Implications for the direct autocrine and paracrine epigenetic regulation of the metastatic process. Int J Cancer 1996;66:151-8.
12. Welch DR, Chen P, Miele ME, McGary CT, Bower JM, Stanbridge EJ, et al. Microcell-mediated transfer of chromosome 6 into metastatic human C8161 melanoma cells suppresses metastasis but does not inhibit tumorigenicity. Oncogene 1994;9:255-62.
13. Miele ME, Robertson G, Lee JH, Coleman A, McGary CT, Fisher PB, et al. Metastasis suppressed, but tumorigenicity and local invasiveness unaffected, in the human melanoma cell line Me/JuSo after introduction of human chromosomes 1 or 6. Mol Carcinog 1996;15:284-99.
14. You J, Miele ME, Dong C, Welch DR. Suppression of human melanoma metastasis by introduction of chromosome 6 may be partially due to inhibition of motility, but not to inhibition of invasion. Biochem Biophys Res Commun 1995;208:476-84.
15. Liang P, Pardee AB. Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction [see comment citation in Medline]. Science 1992;257:967-71.
16. Liang P, Averboukh L, Pardee AB. Distribution and cloning of eukaryotic mRNAs by means of differential display: refinements and optimization. Nucleic Acids Res 1993;21:3269-75.
17. van Groningen JJ, Bloemers HP, Swan GW. Identification of melanoma inhibitory activity and other differentially expressed messenger RNAs in human melanoma cell lines with different metastatic capacity by messenger RNA differential display. Cancer Res 1995;55:6237-43.
18. Lee SW, Tomasetto C, Sager R. Positive selection of candidate tumor-suppressor genes by subtractive hybridization. Proc Natl Acad Sci U S A 1991;88:2825-9.
19. Duguid JR, Rohwer RG, Seed B. Isolation of cDNAs of scrapie-modulated RNAs by subtractive hybridization of a cDNA library. Proc Natl Acad Sci USA 1988;85:5738-42.
20. Welch DR, Bisi JE, Miller BE, Conaway D, Seftor EA, Yohem KH, et al. Characterization of a highly invasive and spontaneously metastatic human malignant melanoma cell line. Int J Cancer 1991;47:227-37.
21. Trent JM, Stanbridge EJ, McBride HL, Meese EU, Casey G, Araujo DE, et al. Tumorigenicity in human melanoma cell lines controlled by introduction of human chromosome 6. Science 1990;247:568-71.
22. Gualandi F, Morelli C, Pavan JV, Rimessi P, Sensi A, Bonfatti A, et al. Induction of senescence and control of tumorigenicity in BK virus transformed mouse cells by human chromosome 6. Genes Chromosomes Cancer 1994;10:77-84.
23. Schweinfest CW, Henderson KW, Gu JR, Kottaridis SD, Besbeas S, Panotopoulou E, et al. Subtraction hybridization cDNA libraries from colon carcinoma and hepatic cancer. Genet Anal Tech Appl 1990;7:64-70.
24. Welch DR, Neri A, Nicolson GL. Comparison of spontaneous and 'experimental' metastasis using rat 13762 mammary adenocarcinoma cell clones. Invasion Metastasis 1983;3:65-80.
25. Lee JH, Welch DR. Use of differential display and subtractive hybridization to identify highly expressed genes in metastasis-suppressed chromosome 6/human melanoma hybrids. Proc Am Assoc Cancer Res 1996; 37:530.
26. Cohen GB, Ren R, Baltimore D. Modular binding domains in signal transduction proteins. Cell 1995;80:237-48.
27. Alexandropoulos K, Cheng G, Baltimore D. Proline-rich sequences that bind to Src homology 3 domains with individual specificities. Proc Natl Acad Sci U S A 1995;92:3110-4.
28. von Heijne G. A new method for predicting signal sequence cleavage sites. Nucleic Acids Res 1986;14:4683-90.
29. Hennessey C, Henry JA, May FE, Westley BR, Angus B, Lennard TW. Expression of the antimetastatic gene nm23 in human breast cancer: an association with good prognosis. J Natl Cancer Inst 1991;83:281-5.
30. Musacchio A, Wilmanns M, Saraste M. Structure and function of the SH3 domain. Prog Biophys Mol Biol 1994;61:283-97.
31. Joseph G, Pick E. Peptide walking is a novel method for mapping functional domains in proteins. Its application to the Rac1-dependent activation of NADPH oxidase. J Biol Chem 1995;270:29079-82.
32. Feng S, Chen JK, Yu H, Simon JA, Schreiber SL. Two binding orientations for peptides to the Src SH3 domain: development of a general model for SH3-ligand interactions. Science 1994;266:1241-7.
33. Mayer BJ, Eck MJ. SH3 domains. Minding your p's and q's. Curr Biol 1995;5:364-7.
34. Rickles RJ, Botfield MC, Zhou XM, Henry PA, Brugge JS, Zoller MJ. Phage display selection of ligand residues important for Src homology 3 domain binding specificity. Proc Natl Acad Sci U S A 1995;92:10909-13.
35. Ishino M, Ohba T, Sasaki H, Sasaki T. Molecular cloning of a cDNA encoding a phosphoprotein, Efs, which contains a Src homology 3 domain and associates with Fyn. Oncogene 1995;11:2331-8.
36. Koch CA, Anderson D, Moran MF, Ellis C, Pawson T. SH2 and SH3 domains: elements that control interactions of cytoplasmic signaling proteins. Science 1991;252:668-74.
37. Musacchio A, Noble M, Pauptit R, Wierenga R, Saraste M. Crystal structure of a Src-homology 3 (SH3) domain [see comment citation in Medline]. Nature 1992;359:851-5.
38. Pawson T, Gish GD. SH2 and SH3 domains: from structure to function. Cell 1992;71:359-62.
39. Pawson T, Schlessinger J. SH2 and SH3 domains. Curr Biol 1993;3:434-42.
40. Feller SM, Ren R, Hanafusa H, Baltimore D. SH2 and SH3 domains as molecular adhesives: the interactions of Crk and Abl. TIBS Trends Biochem Sci 1994;19:453-8.
41. Nobes CD, Hall A. Rho, Rac, and cdc42 GTPases regulate the assembly of multimolecular focal complexes associated with actin stress fibers, lamellipodia, and filopodia. Cell 1995;81:53-62.
42. Ridley AJ. Membrane ruffling and signal transduction. Bioessays 1994; 16:321-7.
43. Cantley LC, Auger KR, Carpenter C, Duckworth B, Graziani A, Kapeller R, et al. Oncogenes and signal transduction [published erratum appears in Cell 1991;65:following 914].Cell 1991;64:281-302.
44. Trent JM, Thompson FH, Meyskens FL Jr. Identification of a recurring translocation site involving chromosome 6 in human malignant melanoma. Cancer Res 1989;49:420-3.
45. Guan XY, Meltzer PS, Cao J, Trent JM. Rapid generation of region-specific genomic clones by chromosome microdissection: isolation of DNA from a region frequently deleted in malignant melanoma. Genomics 1992;14:680-4.
46. Millikin D, Meese E, Vogelstein B, Witkowski C, Trent JM. Loss of heterozygosity for loci on the long arm of chromosome 6 in human malignant melanoma. Cancer Res 1991;51:5449-53.